ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

3 links0 made here, not in the record4 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT00329940Safety and RheumatologicTolerability of Letrozolein Postmenopausal PatientsWith Hormone ReceptorPositive Breast CancerNovartis PharmaceuticalsPhase 3 · completedRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSLetrozoleIntervention entry›Nov 18 · Our role rule · TestedTestedAnastrozoleIntervention entry›Nov 10 · Claude Opus 5.5 · Not givenNot given

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Anastrozole

From the registry record1 judgment on this link
Role in the study, from the registry to what was judged
RegistryIntervention entrythe record gives no role
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 10AnastrozoleClaude Opus 5.5Not givenCurrent
Nov 14Breast NeoplasmsOur condition-kind ruleFinest filed termCurrent
Nov 18LetrozoleOur role ruleTestedCurrent
As of nowBreast NeoplasmsOur main-condition rule (R9)Main conditionCurrent